Unknown PHASE4 INTERVENTIONAL 2-arm NCT05294484

Effect of Genetic Polymorphisms of UGT on the PKs of Indapamide in Egyptians (UGT/PKs)

Study on the Effect of Genetic Polymorphisms of Uridine Diphosphate Glucuronosyl Transferase (UGT) on the Pharmacokinetics of Indapamide in Egyptians

Sponsor: Ain Shams University

Conditions Pharmacogenomics

Interventions Indapamide 1.5 MG SR

Updated 4 times since 2022 Last updated: Mar 15, 2022 Started: Mar 15, 2022 Primary completion: Jul 1, 2022 Completion: Oct 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Pharmacogenomics and is currently ongoing. Ain Shams University leads this study, which shows 4 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2024 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Not Yet Recruiting → Unknown Status
Apr 2022 — Jan 2024 [monthly]

Not Yet Recruiting PHASE4

First recorded

Mar 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ain Shams University

Data source: Ain Shams University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.